Explore Over 11,000+ Conditions, Medications, and Symptoms.

Get a personalized feed by signing up for free.

Fournier gangrene

by Alike Medical Team ∙ Updated on June 13, 2023

General

Fournier’s gangrene is a type of necrotizing fasciitis that affects the scrotum, penis or perineum. Necrotizing fasciitis is a life-threatening bacterial infection of soft tissue. Fournier’s gangrene is an infection of the skin, subcutaneous and muscle fascia of the scrotum, penis or perineum caused due to bacterial infection. It is a rare but very dangerous disease.

0 people with Fournier gangrene

Learn from others who are experiencing Fournier gangrene.

statistic

Signs & symptoms

Symptoms at first may include redness, tenderness and swollen genitals and perineum. If the condition worsens, symptoms may include changes in mental state, lethargy, nausea, vomiting, fever, chills, putrid smell and pain around the abdomen.

Diagnosis

Diagnosis is based upon findings from medical history and physical examination. Further evaluation may include imaging tests and blood tests but it is not recommended to stall the treatment for these further tests.

Treatment

Treatment for fournier’s gangrene is surgical debridement which is the removal of the dead tissue from the body so that the condition will not spread. Usually, antibiotics are given as well.

Note

☝ We provide information on prescription and over-the-counter medicines, diagnosis, procedures and lab tests. This material is provided for educational purposes only and is not medical advice, diagnosis or treatment.

Alike Wisdom

Instantly get answers to medical questions with our AI, built from the collective wisdom of our community facing similar experiences

pp-logo

Alike is a transformative platform that goes beyond just bringing together patients; it meticulously connects individuals based on multiple critical factors, such as age, gender, comorbidities, medications, diet, and more, fostering a community of knowledge, support and empathy.

appStoreBtngooglePlayBtn

© 2020-2024 Alike, Inc